The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Net Asset Value(s)

7 Apr 2020 12:16

RNS Number : 0707J
Aberdeen Diversified I&G Trust PLC
07 April 2020
 

Aberdeen Asset Management PLC announces the unaudited net asset values (NAVs) of the following investment companies as at close of business on 6 April 2020. Unless otherwise disclosed, the NAVs have been calculated in accordance with the recommendations of the Association of Investment Companies. In particular: (1) financial assets have been valued on a fair value basis using bid prices, or, if more appropriate, a last trade basis; (2) debt is valued at par and, where applicable, debt is also separately valued at market value (3) diluted NAVs are disclosed where applicable (for this purpose, treasury shares are excluded for the purposes of calculation); and (4) provisions for performance fees are included where applicable.

 

Aberdeen Diversified Income and Growth Trust Undiluted *

Excluding Income

109.03p

Ordinary

Aberdeen Diversified Income and Growth Trust Undiluted *

Including Income

110.51p

Ordinary

Aberdeen Diversified Income and Growth Trust with Debt at Fair Value *

Excluding Income

100.72p

Ordinary

Aberdeen Diversified Income and Growth Trust with Debt at Fair Value *

Including Income

102.20p

Ordinary

 

 

* The Company's unlisted investments, including those in Limited Partnership funds ("LPs"), are valued based on the reported Net Asset Value ("NAV") of such assets as determined by the administrator or General Partner of the LPs and only adjusted by the Directors in consultation with the Manager where further additional information becomes available. Certain alternative investments are valued monthly or report quarterly and the Company's daily announced NAV may therefore not account for the possible impact to valuations caused by COVID-19. However, approximately 70% of the Company's portfolio holdings are priced daily (including UCITs, Emerging Market bonds, listed alternative investment companies and similar).

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVUPUACCUPUGUM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.